Concepedia

Patrick Younan

PY

Statistics

Publications

2

Citations

68

H-Index

2

Active since

2022

Affiliations

Seagen (United States)(Current)

Patrick Younan is an author at Seagen (United States) specializing in immunotherapy, immunogenic cell death induction, and tumor immunology.

ORCID

Publications per year

2022–2023

2

Publications

2

Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

Ryan A. Heiser, Anthony Cao, Weiping Zeng et al. · Molecular Cancer Therapeutics · 2023 · 54 citations · Full text

, , +17

1187 Enfortumab vedotin induces immunogenic cell death, elicits antitumor immune memory, and shows enhanced preclinical activity in combination with immune checkpoint inhibitors

Devra J. Olson, Patrick Younan, Bernard A. Liu et al. · Regular and Young Investigator Award Abstracts · 2022 · 14 citations · Full text

, , +17

1–2 of 2